BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1232572)

  • 21. Pharmacological studies of new indole alkaloids, rugulovasine A and B hydrochloride.
    Nagaoka A; Kikuchi K; Nagawa Y
    Arzneimittelforschung; 1972 Jan; 22(1):137-42. PubMed ID: 5066988
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on Taxus baccata. II. Pharmacological investigation of the total extract of leaves.
    Vohora SB
    Planta Med; 1972 Aug; 22(1):59-65. PubMed ID: 5083249
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticoagulant activity and plasma phosphatidylserine hydrolysis by snake venom phospholipases A2.
    Condrea E; Yang CC; Rosenberg P
    Thromb Haemost; 1983 Apr; 49(2):151. PubMed ID: 6868012
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiovascular and respiratory responses to the venom from the scorpion Leiurus quinquestriatus.
    Ismail M; Osman OH; Ibrahim SA; el-Asmar MF
    East Afr Med J; 1972 Apr; 49(4):273-81. PubMed ID: 5053316
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of the purified thrombin-like and anticoagulant principles of Agkistrodon acutus venom on blood coagulation in vivo.
    Ouyang C; Teng CM
    Toxicon; 1976; 14(1):49-54. PubMed ID: 1258068
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anticoagulant activity of Agkistrodon rhodostoma venom].
    Allori L; Boumis G; Carassai L
    Clin Ter; 1974 Dec; 71(5):409-25. PubMed ID: 4448047
    [No Abstract]   [Full Text] [Related]  

  • 27. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
    Buschmann G; Kühl UG; Rohte O
    Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacology of ryanodine.
    Jenden DJ; Fairhurst AS
    Pharmacol Rev; 1969 Mar; 21(1):1-25. PubMed ID: 4887724
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid)].
    Marmo E; Ungaro B; Giordano L
    Minerva Cardioangiol; 1971 Feb; 19(2):86-115. PubMed ID: 4396734
    [No Abstract]   [Full Text] [Related]  

  • 30. General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol.
    Terai T; Kusunoki T; Kita Y; Yoshida K; Akahane A; Shiokawa Y; Kohno Y; Horiai H; Mori J; Mine Y; Kohsaka M
    Arzneimittelforschung; 1996 Feb; 46(2):185-91. PubMed ID: 8720311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General pharmacological properties of muroctasin.
    Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and respiratory systems in elapidae envenomation.
    Singh GS; Sanyal RK
    Indian J Med Res; 1967 Oct; 55(10):1092-8. PubMed ID: 5594383
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental investigation of 4-(3',4',5'-trimethoxycinnamoyl)-1-piperaziny l-pyrrolidinyl maleate (67350): effect on the cardiovascular system and on certain smooth muscles.
    Marmo E; Caputi AP; Cataldi S
    Farmaco Prat; 1973 Mar; 28(3):132-60. PubMed ID: 4691581
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacologic and toxicologic studies on benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate--a new spasmolytic].
    Osterloh G; Lagler F; Staemmler M; Helm F
    Arzneimittelforschung; 1966 Aug; 16(8):901-10. PubMed ID: 6014722
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological profile of the new antidepressant levoprotiline.
    Noguchi S; Okada M; Inukai T
    Arzneimittelforschung; 1992 Jun; 42(6):787-94. PubMed ID: 1418032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacologic properties of hydrazine derivatives of methylxanthines].
    Krupińska J
    Folia Med Cracov; 1970; 12(2):251-83. PubMed ID: 5433429
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of thallium sulfate on cardiovascular and respiratory systems of various animals.
    Marmo E; Filippelli A; Scafuro M; Matera C; Bile G; Pujia A; Nisticò G
    Zhongguo Yao Li Xue Bao; 1983 Jun; 4(2):119-22. PubMed ID: 6225299
    [No Abstract]   [Full Text] [Related]  

  • 38. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
    Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
    Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of new angiographic contrast media on the cardio-respiratory- and central nervous system].
    sebök ZB; Szlávy L
    Arzneimittelforschung; 1967 Nov; 17(11):1380-6. PubMed ID: 5632272
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of the sulphonic ester of sodium adrenochrome semicarbazone and of adrenochrome semicarbazone on the cardiovascular system and intestinal musculature].
    Marmo E; Caputi AP; Cataldi S
    Minerva Cardioangiol; 1972 Jun; 20(6):303-17. PubMed ID: 5040406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.